国家: 英国
语言: 英文
来源: MHRA (Medicines & Healthcare Products Regulatory Agency)
Desflurane
Baxter Healthcare Ltd
N01AB07
Desflurane
1ml/1ml
Inhalation vapour
Inhalation
No Controlled Drug Status
Valid as a prescribable product
BNF: 15010200; GTIN: 00085412586595
OBJECT 1 DESFLURANE 100% V/V INHALATION VAPOUR, LIQUID Summary of Product Characteristics Updated 05-Mar-2018 | Baxter Healthcare Ltd 1. Name of the medicinal product Desflurane 100% v/v Inhalation vapour, liquid 2. Qualitative and quantitative composition Desflurane, supplied as pure drug substance. 3. Pharmaceutical form Inhalation vapour, liquid 4. Clinical particulars 4.1 Therapeutic indications Desflurane is indicated as an inhalation agent for induction and/or maintenance of anaesthesia for inpatient and outpatient surgery in adults and maintenance of anaesthesia for inpatient and outpatient paediatric surgery. 4.2 Posology and method of administration Method of administration Desflurane is administered by inhalation. Desflurane should only be administered by persons trained in the administration of general anaesthesia using a vaporizer specifically designed and designated for use with desflurane. Premedication Premedication should be selected according to the needs of the individual patient taking into account that salivary secretions are stimulated. The use of anticholinergic drugs is a matter of choice for the anaesthetist. Individualization The administration of general anaesthesia must be individualized based on the patient's response. Effects on Concomitant Therapy Opioids or benzodiazepines decrease the amount of desflurane required to produce anaesthesia. Desflurane decreases the required doses of neuromuscular blocking agents (see Table 2, section 4.5). If added relaxation is required, supplemental doses of muscle relaxants may be used. (See section 4.5) Dosage The minimum alveolar concentration (MAC) of desflurane decreases with increasing patient age. The dose of desflurane should be adjusted accordingly. The MAC has been determined as listed in Table 1. Table 1 MAC for desflurane according to patient age and inhalation mixture (Mean±SD) Age N* 100% Oxygen N* 60% Nitrous Oxide/40% Oxygen 2 weeks 6 9.2±0.0 - - 10 weeks 5 9.4±0.4 - - 9 months 4 10.0±0.7 5 7.5±0.8 2 years 3 9.1±0.6 - - 3 years 阅读完整的文件